Stock Information
ANI Pharmaceuticals Inc (ANIP)
Ticker Symbol: ANIP
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,811.21 mil
Piotroski score: 9
PE Ratio: 15.61
EPS (TTM): 5.00
Revenue (TTM): $44.64 M
Dividend Yield: N/A
ROE: 19.64%
Latest News
-
Implied Volatility Surging for ANI Pharmaceuticals Stock Options
Mon, Sep 28, 2026 2:41 PM
-
ANI Pharmaceuticals: Cortrophin's Q4 Test, With Generics Funding The Build
Thu, Sep 24, 2026 12:15 PM
-
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know
Wed, Sep 23, 2026 9:38 PM
-
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
Wed, Sep 23, 2026 10:55 AM
-
Oppenheimer Initiates Coverage On ANI Pharmaceuticals with Perform Rating, Announces Price Target of $85
Wed, Sep 23, 2026 8:03 AM
-
ANI Pharmaceuticals Receives Final FDA Approval Of Its Abbreviated New Drug Application For Everolimus Tablets For Oral Suspension
Wed, Sep 23, 2026 6:56 AM
Key Financials
Financial data not available
